A recently identified bacterial protein, named BeeR, is contributing to the design of novel anticancer drug delivery systems. Researchers from King’s College London (UK) and the University of ...

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.

Explore how paclitaxel and innovative drug delivery systems are changing cancer treatment and improving therapeutic outcomes.

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...

Cancer drugs like cisplatin are designed to attack tumor cells, but new research shows these therapies can concentrate inside specialized molecular clusters within the nucleus, altering how ...

Anticancer drug discovery has evolved into a multidisciplinary endeavour that integrates medicinal chemistry, biological evaluation and in silico studies to design agents with enhanced efficacy and ...

Fe2O3 nanoparticles and melamine dendrimers, creating a stable, pH-responsive platform for effective doxorubicin delivery in ...

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, ...

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy. However ...